Drug Development in the Pharmaceutical Industry (9/4)
Seminar on Strengthening Transferable Research Skills for Young Researchers - Drug Development in the Pharmaceutical Industry: Career Paths, Current Status, and Future Directions -
This seminar is aimed at early career researchers (DC, PD) to improve transferable skills.
The seminar will be conducted in English. This is your chance to gain new knowledge about the pharmaceutical industry and careers overseas! Questions will be accepted for the lecturer in advance.
overview
Drug development in the pharmaceutical industry is dynamic. When venture companies and startups (including those originating from academia) achieve a certain level of success, large corporations often acquire their research results and enter the large-scale clinical development stage. Clinical development often requires trillions of yen, and companies are racking their brains to reduce costs, streamline processes, and expedite approval. To improve efficiency, many animal experiments and pharmacological testing are outsourced, leading to the development of collaborative relationships with academia. Careers at pharmaceutical companies (sponsors) and contract research organizations (CROs) are fluid, depending on each individual's area of expertise. Understanding the matrix team structure of pharmaceutical companies and the roles of each function is important for future career planning, as it helps identify areas where you can demonstrate your strengths.
Event Details
Lecturer
Ms. Tomoko Nakabachi
Chief Mentor and Director of Novan Medical, Pharmaceutical Development Capacity Promotion Organization
Lecturer brief history
Graduated from Osaka University School of Medicine in 1991.
He completed his graduate studies at the same university in 1996. He completed postdoctoral studies at Boston University and the University of Alberta in Canada. He has worked in clinical dermatology at the Department of Dermatology, Osaka University School of Medicine and the Department of Dermatology, Osaka Koseinenkin Hospital.
Obtained specialist certification in dermatology in 1998.
In 2002, he became the Japan Development Team Leader at Pfizer Japan, where he was involved in the development of new drugs for osteoporosis, hypertension, and hyperlipidemia, as well as dealing with authorities.
In 2006, he transferred to Pfizer US, where he led global development in the fields of ophthalmology and psoriasis vulgaris. He then served as Senior Medical Advisor at Eli Lilly and Senior Medical Director at GlaxoSmithKline, where he was involved in the formulation and implementation of global clinical development plans for various dermatological diseases, as well as in dealing with and negotiating with authorities such as the FDA (USA), EMA (Europe), and PMDA (Japan).
Vice President (Medical) of Novan, Inc. since 2017.
In 2019, he founded the nonprofit organization, the Organization for Promoting Capacity Development in Drug Development, as part of his efforts to raise awareness of drug development. He currently resides in Durham, North Carolina.
Date
Friday, September 4, 2020 9:00-10:30
Place
online
*Live from the US
Language used
English
Target Audience
DC、PD、MC
Application period
Until Friday, August 28, 2020 (Extended)
*Applicants will be sent a questionnaire in advance.
Please take a look at the website of the DDCP (Drug Development Capacity Promotion Organization), to which the lecturer belongs, and send in any questions you may have, such as "I'd like to hear more about this" or "I'd like to ask about something that's not written here," by August 19th. (Japanese OK)
▽DDCP (Drug Development Capacity Promotion Organization)
https://ddcp-med.com/
Capacity
90 people
How to apply through Hi-System
Click on the banner below and press the "Apply" button at the bottom.
*Hi-system registration required: Click here for details
Hi-System